BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 28758337)

  • 1. Changes in the distribution of colonising and infecting Candida spp. isolates, antifungal drug consumption and susceptibility in a French intensive care unit: A 10-year study.
    Sasso M; Roger C; Sasso M; Poujol H; Barbar S; Lefrant JY; Lachaud L
    Mycoses; 2017 Dec; 60(12):770-780. PubMed ID: 28758337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. - Trends over 10 years.
    Bailly S; Maubon D; Fournier P; Pelloux H; Schwebel C; Chapuis C; Foroni L; Cornet M; Timsit JF
    J Infect; 2016 Jan; 72(1):103-11. PubMed ID: 26518058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal use influences Candida species distribution and susceptibility in the intensive care unit.
    Fournier P; Schwebel C; Maubon D; Vesin A; Lebeau B; Foroni L; Hamidfar-Roy R; Cornet M; Timsit JF; Pelloux H
    J Antimicrob Chemother; 2011 Dec; 66(12):2880-6. PubMed ID: 21980066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
    Pfaller MA; Messer SA; Moet GJ; Jones RN; Castanheira M
    Int J Antimicrob Agents; 2011 Jul; 38(1):65-9. PubMed ID: 21514797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida infection in the intensive care unit: A study of antifungal susceptibility pattern of Candida species in Milad hospital, Tehran, Iran.
    Alimehr S; Shekari Ebrahim Abad H; Fallah F; Rahbar M; Mohammadzadeh M; Vossoghian S; Rafeei Tabatabaee S; Roudbary M; Zaini F
    J Mycol Med; 2015 Dec; 25(4):e113-7. PubMed ID: 26563641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-abdominal candidiasis in surgical intensive care unit - epidemiology characteristics and trends.
    Ulrych J; Adámková V; Matek J; Komarc M; Frýba V; Schmidt D; Koželský P; Studená A; Bříza J; Krška Z
    Epidemiol Mikrobiol Imunol; 2020; 69(2):57-63. PubMed ID: 32819104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between antifungal consumption and the distribution of Candida species in different hospital departments of a Lebanese medical Centre.
    Awad L; Tamim H; Abdallah D; Salameh M; Mugharbil A; Jisr T; Zahran K; Droubi N; Ibrahim A; Moghnieh R
    BMC Infect Dis; 2018 Nov; 18(1):589. PubMed ID: 30453891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.
    Bedini A; Venturelli C; Mussini C; Guaraldi G; Codeluppi M; Borghi V; Rumpianesi F; Barchiesi F; Esposito R
    Clin Microbiol Infect; 2006 Jan; 12(1):75-80. PubMed ID: 16460550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for isolation of fluconazole and echinocandin non-susceptible
    Papadimitriou-Olivgeris M; Spiliopoulou A; Fligou F; Tsiata E; Kolonitsiou F; Nikolopoulou A; Papamichail C; Spiliopoulou I; Marangos M; Christofidou M
    J Med Microbiol; 2021 Aug; 70(8):. PubMed ID: 34431765
    [No Abstract]   [Full Text] [Related]  

  • 12. Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates.
    Roilides E; Farmaki E; Evdoridou J; Dotis J; Hatziioannidis E; Tsivitanidou M; Bibashi E; Filioti I; Sofianou D; Gil-Lamaignere C; Mueller FM; Kremenopoulos G
    Eur J Clin Microbiol Infect Dis; 2004 Oct; 23(10):745-50. PubMed ID: 15605181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units.
    Montravers P; Mira JP; Gangneux JP; Leroy O; Lortholary O;
    Clin Microbiol Infect; 2011 Jul; 17(7):1061-7. PubMed ID: 20825438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida glabrata fungaemia in intensive care units.
    Ruan SY; Lee LN; Jerng JS; Yu CJ; Hsueh PR
    Clin Microbiol Infect; 2008 Feb; 14(2):136-40. PubMed ID: 18042196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal susceptibility profiles of Candida isolates from a prospective survey of invasive fungal infections in Italian intensive care units.
    Tortorano AM; Prigitano A; Dho G; Grancini A; Passera M; For The Ecmm-Fimua Study Group
    J Med Microbiol; 2012 Mar; 61(Pt 3):389-393. PubMed ID: 22096131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study.
    Tan TY; Tan AL; Tee NW; Ng LS; Chee CW
    Mycoses; 2010 Nov; 53(6):515-21. PubMed ID: 19619263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of nosocomial candidaemia in a university hospital: a 12-year study.
    Gürcüoğlu E; Ener B; Akalin H; Sinirtaş M; Evci C; Akçağlar S; Yilmaz E; Heper Y
    Epidemiol Infect; 2010 Sep; 138(9):1328-35. PubMed ID: 20056017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antifungal susceptibility of Candida spp. isolates from blood cultures in a five-year period (1997-2001)].
    Durán MT; Velasco D; Canle D; Moure R; Villanueva R
    Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):488-92. PubMed ID: 14572381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
    Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E
    Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing pattern of candidaemia 2001-2006 and use of antifungal therapy at the University Hospital of Vienna, Austria.
    Presterl E; Daxböck F; Graninger W; Willinger B
    Clin Microbiol Infect; 2007 Nov; 13(11):1072-6. PubMed ID: 17725647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.